ArticleInternational journal of molecular sciences2022

Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity.

Ji Sun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.